About Leveragen
Leveragen is a company based in Cambridge (United States) founded in 2017 by Weisheng V Chen. Leveragen offers products and services including Genetic Engineering Platform and Antibody Discovery Platform. Leveragen operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.
- Headquarter Cambridge, United States
- Founders Weisheng V Chen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leveragen, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leveragen
Leveragen offers a comprehensive portfolio of products and services, including Genetic Engineering Platform and Antibody Discovery Platform.
Platform for genome editing and biotherapeutics development using CRISPR
System for identifying and engineering antibodies via phage display
People of Leveragen
Unlock access to complete
Leadership Team
3 people
Principal Team
2 people
Software Development Team
1 people
Principle Team
1 people
Unlock access to complete
Funding Insights of Leveragen
Detailed funding history for Leveragen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Leveragen
Investment portfolio details for Leveragen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Leveragen
Detailed financials for Leveragen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leveragen Comparisons
Peer comparison for Leveragen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Leveragen
Leveragen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Strateos and Beikang Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
Provider of cloud based platform provides data driven information for biotech research
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
Detailed competitors of Leveragen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leveragen
Complete news archive for Leveragen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leveragen
Leveragen was founded in 2017.
Leveragen is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Leveragen was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where customized genetic modeling services are delivered through CRISPR-facilitated gene targeting in embryonic stem cells. Mutations are screened in these cells prior to knockout mouse development, enabling large fragment knockins and complex genetic modifications for research applications.
Leveragen's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Leveragen offers Genetic Engineering Platform and Antibody Discovery Platform.